| 000 | 01657 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518031149.0 | ||
| 264 | 0 | _c20200720 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a2047-9980 | ||
| 024 | 7 |
_a10.1161/JAHA.118.011581 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, Safi U | |
| 245 | 0 | 0 |
_aAssociation of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis. _h[electronic resource] |
| 260 |
_bJournal of the American Heart Association _c04 2019 |
||
| 300 |
_ae011581 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Systematic Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCholesterol, LDL _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xchemically induced |
| 650 | 0 | 4 |
_aEzetimibe _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aPCSK9 Inhibitors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aRahman, Hammad | |
| 700 | 1 | _aOkunrintemi, Victor | |
| 700 | 1 | _aRiaz, Haris | |
| 700 | 1 | _aKhan, Muhammad Shahzeb | |
| 700 | 1 | _aSattur, Sudhakar | |
| 700 | 1 | _aKaluski, Edo | |
| 700 | 1 | _aLincoff, A Michael | |
| 700 | 1 | _aMartin, Seth S | |
| 700 | 1 | _aBlaha, Michael J | |
| 773 | 0 |
_tJournal of the American Heart Association _gvol. 8 _gno. 7 _gp. e011581 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/JAHA.118.011581 _zAvailable from publisher's website |
| 999 |
_c29503519 _d29503519 |
||